Ali Marhaba, MD Internal Medicine - Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 40 Mitchell Ave, Binghamton, NY 13903 Phone: 607-772-0639 |
Mohammad Abidi, MD Internal Medicine - Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 40 Mitchell Ave, Binghamton, NY 13903 Phone: 607-772-0639 |
Alan S Lerman, M.D. Internal Medicine - Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 161 Riverside Dr, Suite 210, Binghamton, NY 13905 Phone: 607-770-1155 Fax: 607-770-1968 |
Mark Shumeyko, MD Internal Medicine - Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 40 Mitchell Ave, Binghamton, NY 13903 Phone: 607-772-0639 |
Amine Hila, MD Internal Medicine - Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 40 Mitchell Ave, Third Floor, Binghamton, NY 13903 Phone: 607-772-0639 Fax: 607-722-4610 |
Dr. Steven R Hassig, M.D. Internal Medicine - Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 161 Riverside Drive, Suite 102, Binghamton, NY 13905 Phone: 607-729-1444 Fax: 607-729-7086 |
Richard L Blansky, M.D. Internal Medicine - Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 161 Riverside Dr, Suite 210, Binghamton, NY 13905 Phone: 607-770-1155 Fax: 607-770-1968 |
News Archive
It's a great pleasure, in this week when the entire political world is hanging on the Supreme Court's health care ruling, to welcome so many liberals to a cause dear to my heart: The crusade for judicial restraint.
Roche today announced the launch of the cobas Liat System—a fast, compact , easy to use, molecular diagnostic platform, designed for on-demand testing in physician clinics, pharmacies and hospital lab settings.
New research findings published today in the BMJ helps to shed light on the risks of COVID-19 for pregnant women and their babies.
Tetraphase Pharmaceuticals, Inc. (NASDAQ:TTPH) today provided a clinical update on its lead antibiotic candidate, eravacycline, and its Phase 3 global clinical program IGNITE (Investigating Gram-negative Infections Treated with Eravacycline).
› Verified 8 days ago